Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

1386824

registered interest
date	09/12/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Children: Protection
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government, further to the Written Answer by Lord Kamall on 17 November (HL3974), how many unborn children have been placed on the Child Protection Information sharing system using the pregnant woman’s National Health Service number.
tabling member printed	Lord Walney
uin	HL4851
answer	answer is ministerial correction date of answer 16/12/2021 answer text <p>The information is not available and could only be obtained at disproportionate cost.</p> answering member printed Lord Kamall question first answered 16/12/2021 15:36:00 answering member 4909 label Biography information for Lord Kamall
tabling member	3917 label Biography information for Lord Walney

1367793

registered interest
date	10/11/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Children: Protection
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what plans they have to include pregnant women whose children are likely to need a care plan from birth in the Child Protection – Information Sharing Project.
tabling member printed	Lord Walney
uin	HL3974
answer	answer is ministerial correction date of answer 17/11/2021 answer text <p>Unborn children on a protection plan can be on the Children Protection – Information Sharing system with the pregnant woman’s National Health Service number.</p> answering member printed Lord Kamall question first answered 17/11/2021 16:40:44 answering member 4909 label Biography information for Lord Kamall
tabling member	3917 label Biography information for Lord Walney

1254024

registered interest
date	19/11/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Immunosuppression: Coronavirus
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what steps they are taking to support immunocompromised people who will not be able to benefit from a COVID-19 vaccine.
tabling member printed	Lord Walney
uin	HL10552
answer	answer is ministerial correction date of answer 01/12/2020 answer text <p>The Government is exploring all avenues available to us, to ensure that a treatment for COVID-19 is found. Treatments containing COVID-19 neutralising antibodies have been secured from AstraZenaca to support immunocompromised people who will not be able to benefit from a COVID-19 vaccine. The antibody treatment currently being developed by AstraZeneca is a combination of two monoclonal antibodies and has the potential to be given as a preventative option for people exposed to the virus, and to treat and prevent disease progression in patients already infected by the virus if successful. ​</p> answering member printed Lord Bethell question first answered 01/12/2020 12:04:41 answering member 4708 label Biography information for Lord Bethell
tabling member	3917 label Biography information for Lord Walney

1254025

registered interest
date	19/11/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Immunosuppression: Coronavirus
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what steps they plan to take to prevent COVID-19 infection in immunocompromised people who will not be able to benefit from a COVID-19 vaccine.
tabling member printed	Lord Walney
uin	HL10553
answer	answer is ministerial correction date of answer 10/12/2020 answer text <p>The Government is exploring all avenues available to us, to ensure that a treatment for COVID-19 is found., Treatments containing COVID-19 neutralising antibodies have been secured from AstraZenaca in order to prevent COVID-19 infection in immunocompromised people who will not be able to benefit from a COVID-19 vaccine. The antibody treatment currently being developed by AstraZeneca is a combination of two monoclonal antibodies and has the potential to be given as a preventative option for people exposed to the virus, and to treat and prevent disease progression in patients already infected by the virus if successful. ​</p> answering member printed Lord Bethell question first answered 10/12/2020 14:48:00 answering member 4708 label Biography information for Lord Bethell
tabling member	3917 label Biography information for Lord Walney

1254026

registered interest
date	19/11/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Immunosuppression: Coronavirus
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what estimate they have made of the number of immunocompromised people in England who will not be able to benefit from a COVID-19 vaccine; and what discussions they have had with the (1) Scottish, (2) Welsh, and (3) Northern Irish, Governments about the numbers of those people in those countries.
tabling member printed	Lord Walney
uin	HL10554
answer	answer is ministerial correction date of answer 13/01/2021 answer text <p>The Department has worked closely at Ministerial and official level with our partners in the devolved administrations since the beginning of the outbreak, discussing a broad range of issues, in order to formulate an effective response.</p><p>Both primary immunodeficiency, the result of an inherited genetic defect, and secondary immunodeficiency, the result of disease or treatment and which may be temporary, have a variety of causes. Incidence, diagnosis or overall collective prevalence data that capture all possible types of immune deficiency, are not routinely collected or recorded centrally.</p><p>The Green Book lists the immunocompromised as part of the clinical risk groups over the age of 18 years old who should receive COVID-19 immunisation, as recommended by the latest advice from the Joint Committee on Vaccination and Immunisation (JCVI), but notes that some immunocompromised patients may have a suboptimal immunological response to the vaccine. The JCVI has considered vaccination of household contacts of immunosuppressed individuals. However, at this time there is no data on the size of the effect of COVID-19 vaccines on transmission. Once enough evidence becomes available, the JCVI will consider options for a cocooning strategy for immunosuppressed individuals, including whether any specific vaccine is preferred for this population.</p> answering member printed Lord Bethell grouped question UIN HL10555 HL10556 question first answered 13/01/2021 12:04:32 answering member 4708 label Biography information for Lord Bethell
tabling member	3917 label Biography information for Lord Walney

1254027

registered interest
date	19/11/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Immunosuppression: Coronavirus
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government which health conditions or treatments they categorised as resulting in a patient being immunocompromised when making their estimate of the total number of immunocompromised people who will not be able to benefit from a COVID-19 vaccine.
tabling member printed	Lord Walney
uin	HL10555
answer	answer is ministerial correction date of answer 13/01/2021 answer text <p>The Department has worked closely at Ministerial and official level with our partners in the devolved administrations since the beginning of the outbreak, discussing a broad range of issues, in order to formulate an effective response.</p><p>Both primary immunodeficiency, the result of an inherited genetic defect, and secondary immunodeficiency, the result of disease or treatment and which may be temporary, have a variety of causes. Incidence, diagnosis or overall collective prevalence data that capture all possible types of immune deficiency, are not routinely collected or recorded centrally.</p><p>The Green Book lists the immunocompromised as part of the clinical risk groups over the age of 18 years old who should receive COVID-19 immunisation, as recommended by the latest advice from the Joint Committee on Vaccination and Immunisation (JCVI), but notes that some immunocompromised patients may have a suboptimal immunological response to the vaccine. The JCVI has considered vaccination of household contacts of immunosuppressed individuals. However, at this time there is no data on the size of the effect of COVID-19 vaccines on transmission. Once enough evidence becomes available, the JCVI will consider options for a cocooning strategy for immunosuppressed individuals, including whether any specific vaccine is preferred for this population.</p> answering member printed Lord Bethell grouped question UIN HL10554 HL10556 question first answered 13/01/2021 12:04:32 answering member 4708 label Biography information for Lord Bethell
tabling member	3917 label Biography information for Lord Walney

1254028

registered interest
date	19/11/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Immunosuppression: Coronavirus
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what plans they have to provide a breakdown (1) by health condition or treatment, and (2) by age group, of any estimate of the number of immunocompromised people who will not be able to benefit from a COVID-19 vaccine.
tabling member printed	Lord Walney
uin	HL10556
answer	answer is ministerial correction date of answer 13/01/2021 answer text <p>The Department has worked closely at Ministerial and official level with our partners in the devolved administrations since the beginning of the outbreak, discussing a broad range of issues, in order to formulate an effective response.</p><p>Both primary immunodeficiency, the result of an inherited genetic defect, and secondary immunodeficiency, the result of disease or treatment and which may be temporary, have a variety of causes. Incidence, diagnosis or overall collective prevalence data that capture all possible types of immune deficiency, are not routinely collected or recorded centrally.</p><p>The Green Book lists the immunocompromised as part of the clinical risk groups over the age of 18 years old who should receive COVID-19 immunisation, as recommended by the latest advice from the Joint Committee on Vaccination and Immunisation (JCVI), but notes that some immunocompromised patients may have a suboptimal immunological response to the vaccine. The JCVI has considered vaccination of household contacts of immunosuppressed individuals. However, at this time there is no data on the size of the effect of COVID-19 vaccines on transmission. Once enough evidence becomes available, the JCVI will consider options for a cocooning strategy for immunosuppressed individuals, including whether any specific vaccine is preferred for this population.</p> answering member printed Lord Bethell grouped question UIN HL10554 HL10555 question first answered 13/01/2021 12:04:32 answering member 4708 label Biography information for Lord Bethell
tabling member	3917 label Biography information for Lord Walney

1249039

registered interest
date	04/11/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Disease Control
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what plans they have to publish in full the modelling and assumptions that informed the Winter scenarios from early working analysis England: daily deaths if no changes in policy or behaviour slide, publicised on 31 October.
tabling member printed	Lord Walney
uin	HL10027
answer	answer is ministerial correction date of answer 01/12/2020 answer text <p>The Chief Medical Officer’s presentation of 31 October and the accompanying modelling has been published online at GOV.UK. A copy of the presentation is attached.</p> answering member printed Lord Bethell grouped question UIN HL10028 question first answered 01/12/2020 12:04:12 answering member 4708 label Biography information for Lord Bethell attachment 1 file name HL10027 - Slides_to_accompany_coronavirus_press_conference-_CMO-_31_October_2020.pdf title Slides to accompany Covid-19 Press Conference
tabling member	3917 label Biography information for Lord Walney

1249040

registered interest
date	04/11/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Epidemiology
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what plans they have to publish in full the modelling and assumptions informing the Scientific Pandemic Influenza modelling group (SPI-M) medium term projection for the next six weeks, publicised on 31 October.
tabling member printed	Lord Walney
uin	HL10028
answer	answer is ministerial correction date of answer 01/12/2020 answer text <p>The Chief Medical Officer’s presentation of 31 October and the accompanying modelling has been published online at GOV.UK. A copy of the presentation is attached.</p> answering member printed Lord Bethell grouped question UIN HL10027 question first answered 01/12/2020 12:04:12 answering member 4708 label Biography information for Lord Bethell attachment 1 file name HL10027 - Slides_to_accompany_coronavirus_press_conference-_CMO-_31_October_2020.pdf title Slides to accompany Covid-19 Press Conference
tabling member	3917 label Biography information for Lord Walney

1248066

registered interest
date	02/11/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Contact Tracing
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what plans they have to improve connectivity between the national COVID-19 contact tracing system and local outbreak control systems; and if they have any such plans, what are the timescales by which they expect to make any such changes.
tabling member printed	Lord Walney
uin	HL9894
answer	answer is ministerial correction date of answer 15/12/2020 answer text <p>Since its inception, NHS Test and Trace has worked closely with local authorities and local directors of public health.</p><p> </p><p>Local Tracing Partnerships, first announced on 5 August, use local knowledge about communities and individuals to help ensure contact tracers reach the greatest possible proportion of people who have tested positive, both to help identify any support needs for them and other members of their households and to gather information about their recent contacts. As at 8 December, 275 Local Tracing Partnerships are in place, with more in implementation.</p><p>Local Tracing Partnerships involve local and national teams working together and sharing data as appropriate to ensure an integrated approach to contact tracing, support for self-isolation and preventing and managing local outbreaks.</p> answering member printed Lord Bethell question first answered 15/12/2020 16:53:22 answering member 4708 label Biography information for Lord Bethell
tabling member	3917 label Biography information for Lord Walney